A recent systematic review published in JAMA Internal Medicine underscored the ongoing underrepresentation of women in medical device clinical trials. In a review of 195 trials which were majority conducted between 2013 and 2022, study researchers uncovered that only about one-third of participants evaluating medical devices were women. Additionally, they found that the percentage of women included as participants in studies over the decades have not increased over time.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,